
Glimihelp PM 1mg/500mg/15mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimihelp PM 1mg/500mg/15mg Tablet
Diabetic patients may find relief with the combined-action Glyburide/Metformin/Pioglitazone tablet (1mg/500mg/15mg), which aids in regulating blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thereby reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen. Take this medication with food to minimize gastrointestinal discomfort. For a missed dose, take it promptly; however, if the next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose. Overdosage can trigger hypoglycemia. Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function tests will be evaluated before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Glimihelp PM 1mg/500mg/15mg Tablet
There is no text provided to rephrase.
Uses of Glimihelp PM 1mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimihelp PM 1mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimihelp PM 1mg/500mg/15mg tablets with food.
Common Side effects of Glimihelp PM 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimihelp PM 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glimihelp PM 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing. Consume with food.
How Glimihelp PM 1mg/500mg/15mg Tablet works:
Glimihelp PM 1mg/500mg/15mg tablets combine three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone, offering enhanced blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimihelp PM 1mg/500mg/15mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimihelp PM 1mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Using Glimihelp PM 1mg/500mg/15mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimihelp PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimihelp PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Glimihelp PM 1mg/500mg/15mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimihelp PM 1mg/500mg/15mg Tablet :
Should you forget a Glimihelp PM 1mg/500mg/15mg Tablet dose, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Glimihelp PM 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
